Human immunity to rat antigens. II. Immune responses in dialysis patients.
The immune status of 35 patients with renal failure was studied shortly after they had commenced treatment by chronic haemodialysis to see if a group with poor immunological responses could be identified. Of 27 patients who were unimmunised to start with, only two developed lymphocytoxic antibodies after a year of treatment. The routine immunological tests that were carried out on these patients failed to predict which of them would develop antibodies, and the values that were obtained for the group of cytotoxic negative patients were no different from those obtained for the two patients who became immunised and six others who had previously rejected a kidney transplant. By using a new test that measured cellular immunity to rat antigens, eight patients could be identified as "poor responders." These individuals had in addition failed to develop cytotoxic antibodies during dialysis, had serum IgG levels that were significantly lower than normal, and were uniformly unresponsive to purified protein derivative. This group of patients might be a favoruable one to transplant.
D000818:Animals; D000917:Antibody Formation; D000918:Antibody Specificity; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D006087:Graft vs Host Reaction; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000276:immunology* / Q000628:therapy; D016030:Kidney Transplantation; D008297:Male; D051381:Rats; D006435:Renal Dialysis; D012882:Skin Tests; D013997:Time Factors; D014184:Transplantation, Homologous